報價延遲最少15分鐘:2025/06/01 18:08 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.7253 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.21/-0.47
|
|
企業價值
29.68M
|
| 資產負債 |
|
每股賬面淨值
0.06
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/01 18:08 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal. |